VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 112 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,205,215 | -43.6% | 278,985 | -13.9% | 0.11% | -34.1% |
Q2 2023 | $2,135,641 | -34.8% | 324,073 | -32.9% | 0.17% | -36.4% |
Q1 2023 | $3,277,513 | -59.2% | 482,697 | -55.6% | 0.27% | -60.3% |
Q4 2022 | $8,037,416 | -62.4% | 1,087,607 | -49.8% | 0.68% | -59.5% |
Q3 2022 | $21,402,000 | -21.2% | 2,166,156 | -13.0% | 1.69% | -28.5% |
Q2 2022 | $27,154,000 | -3.6% | 2,491,200 | 0.0% | 2.37% | +8.7% |
Q1 2022 | $28,175,000 | -36.6% | 2,491,200 | -12.1% | 2.18% | -23.4% |
Q4 2021 | $44,469,000 | -31.6% | 2,834,244 | -25.3% | 2.84% | -27.6% |
Q3 2021 | $64,992,000 | -20.3% | 3,791,805 | 0.0% | 3.92% | -12.7% |
Q2 2021 | $81,562,000 | +43.2% | 3,791,805 | 0.0% | 4.50% | +38.5% |
Q1 2021 | $56,953,000 | +2.5% | 3,791,805 | -10.4% | 3.24% | +11.4% |
Q4 2020 | $55,589,000 | +38.0% | 4,230,548 | +1.4% | 2.91% | +31.8% |
Q3 2020 | $40,285,000 | -14.5% | 4,170,281 | +1.3% | 2.21% | -21.8% |
Q2 2020 | $47,093,000 | +9.9% | 4,116,548 | -0.4% | 2.83% | -21.2% |
Q1 2020 | $42,837,000 | -42.3% | 4,134,846 | -8.6% | 3.59% | -12.3% |
Q4 2019 | $74,263,000 | +22.1% | 4,525,476 | -1.2% | 4.09% | +0.9% |
Q3 2019 | $60,838,000 | -14.6% | 4,581,176 | -9.4% | 4.05% | +17.0% |
Q2 2019 | $71,226,000 | -23.4% | 5,055,050 | 0.0% | 3.46% | -10.7% |
Q1 2019 | $93,013,000 | -14.3% | 5,055,050 | +21.6% | 3.88% | -32.9% |
Q4 2018 | $108,588,000 | +13.9% | 4,155,670 | 0.0% | 5.78% | +50.0% |
Q3 2018 | $95,373,000 | +20.5% | 4,155,670 | 0.0% | 3.86% | +21.8% |
Q2 2018 | $79,166,000 | +13.1% | 4,155,670 | 0.0% | 3.16% | +5.7% |
Q1 2018 | $70,023,000 | +10.9% | 4,155,670 | 0.0% | 2.99% | +10.1% |
Q4 2017 | $63,166,000 | -15.1% | 4,155,670 | 0.0% | 2.72% | -13.2% |
Q3 2017 | $74,386,000 | +8.6% | 4,155,670 | -1.1% | 3.13% | -2.0% |
Q2 2017 | $68,513,000 | +16.4% | 4,203,270 | 0.0% | 3.20% | +15.0% |
Q1 2017 | $58,846,000 | -12.2% | 4,203,270 | 0.0% | 2.78% | -27.3% |
Q4 2016 | $67,042,000 | -2.0% | 4,203,270 | +2.3% | 3.82% | -3.7% |
Q3 2016 | $68,402,000 | +44.7% | 4,110,708 | -2.7% | 3.97% | +11.2% |
Q2 2016 | $47,285,000 | +40.3% | 4,225,608 | +4.8% | 3.57% | +36.5% |
Q1 2016 | $33,698,000 | -10.2% | 4,030,908 | 0.0% | 2.62% | +25.2% |
Q4 2015 | $37,528,000 | -16.8% | 4,030,908 | +0.8% | 2.09% | -3.6% |
Q3 2015 | $45,087,000 | -8.8% | 3,997,108 | +2.6% | 2.17% | -1.4% |
Q2 2015 | $49,458,000 | +39.8% | 3,897,408 | +2.5% | 2.20% | +25.7% |
Q1 2015 | $35,372,000 | -34.8% | 3,803,408 | +0.4% | 1.75% | -45.1% |
Q4 2014 | $54,229,000 | +59.1% | 3,786,908 | +15.3% | 3.18% | +25.0% |
Q3 2014 | $34,079,000 | -35.0% | 3,283,124 | +1.3% | 2.55% | -34.8% |
Q2 2014 | $52,430,000 | -49.8% | 3,240,424 | -49.6% | 3.90% | -9.6% |
Q1 2014 | $104,502,000 | +160.0% | 6,430,848 | +98.6% | 4.32% | +15.2% |
Q4 2013 | $40,191,000 | +26.2% | 3,238,624 | +11.4% | 3.75% | +12.3% |
Q3 2013 | $31,846,000 | +65.5% | 2,908,314 | +22.1% | 3.34% | +47.0% |
Q2 2013 | $19,246,000 | – | 2,381,876 | – | 2.27% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Signpost Capital Advisors, LP | 1,688,952 | $27,327,000 | 10.37% |
Palo Alto Investors LP | 3,240,424 | $52,430,000 | 3.90% |
Parametrica Management Ltd | 12,509 | $202,000 | 1.53% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,740,400 | $28,160,000 | 1.08% |
PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 557,100 | $9,014,000 | 1.07% |
Westend Capital Management, LLC | 64,086 | $841,000 | 1.00% |
WALL STREET ASSOCIATES | 702,700 | $11,370,000 | 0.98% |
Baker Brothers Advisors | 4,372,153 | $70,741,000 | 0.87% |
Iguana Healthcare Management, LLC | 100,000 | $1,618,000 | 0.76% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,085,301 | $17,560,000 | 0.71% |